SSTR2 and neoplasm: The development of peptide receptor radionuclide therapy (PRRT) has introduced a promising therapeutic strategy by leveraging SSTR2 expression to enable highly sensitive imaging of small tumors and the delivery of targeted radiation directly to tumor cells.